Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin J Dedes

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Breast Disease|October 24, 2009
Clinical presentation and surgical management of invasive lobular carcinoma of the breastKonstantin J Dedes, Daniel Fink
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 14, 2009
Is cancer prevention ever going to be profitable?Thomas D Szucs, Konstantin J Dedes
Gynakologisch-Geburtshilfliche Rundschau|June 21, 2008
[Current adjuvant endocrine treatment of breast cancer]Konstantin J Dedes, Natalie Gabriel, Daniel Fink
Praxis|October 14, 2020
[Rare Forms of Mastitis]Denise Vorburger, Heike Frauchiger-Heuer, Konstantin J Dedes
Cardiovascular Drugs and Therapy|September 28, 2005
Pharmacotherapy of acute coronary syndromes: medical economics with an emphasis on clopidogrelMatthias Bramkamp, Konstantin J Dedes, Thomas D Szucs
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Paclitaxel: cost-effectiveness in ovarian cancerKonstantin J Dedes, Matthias Bramkamp, Thomas D Szucs
Pharmacoeconomics|June 8, 2010
Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic reviewPatricia R Blank, Konstantin J Dedes, Thomas D Szucs
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 22, 2005
Postoperative bezoar ileus after early enteral feedingKonstantin J Dedes, Marc Schiesser, Markus Schäfer, et al.
Targeted Oncology|December 17, 2014
Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literatureIsabel Ihnenfeld Arciénega, Patrick Imesch, Daniel Fink, et al.
International Journal of Oncology|July 30, 2009
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cellsPatrick Imesch, Konstantin J Dedes, Michele Furlato, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Breast Disease|October 24, 2009
Clinical presentation and surgical management of invasive lobular carcinoma of the breastKonstantin J Dedes, Daniel Fink
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 14, 2009
Is cancer prevention ever going to be profitable?Thomas D Szucs, Konstantin J Dedes
Gynakologisch-Geburtshilfliche Rundschau|June 21, 2008
[Current adjuvant endocrine treatment of breast cancer]Konstantin J Dedes, Natalie Gabriel, Daniel Fink
Praxis|October 14, 2020
[Rare Forms of Mastitis]Denise Vorburger, Heike Frauchiger-Heuer, Konstantin J Dedes
Cardiovascular Drugs and Therapy|September 28, 2005
Pharmacotherapy of acute coronary syndromes: medical economics with an emphasis on clopidogrelMatthias Bramkamp, Konstantin J Dedes, Thomas D Szucs
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Paclitaxel: cost-effectiveness in ovarian cancerKonstantin J Dedes, Matthias Bramkamp, Thomas D Szucs
Pharmacoeconomics|June 8, 2010
Cost effectiveness of cytotoxic and targeted therapy for metastatic breast cancer: a critical and systematic reviewPatricia R Blank, Konstantin J Dedes, Thomas D Szucs
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 22, 2005
Postoperative bezoar ileus after early enteral feedingKonstantin J Dedes, Marc Schiesser, Markus Schäfer, et al.
Targeted Oncology|December 17, 2014
Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literatureIsabel Ihnenfeld Arciénega, Patrick Imesch, Daniel Fink, et al.
International Journal of Oncology|July 30, 2009
MLH1 protects from resistance acquisition by the histone deacetylase inhibitor trichostatin A in colon tumor cellsPatrick Imesch, Konstantin J Dedes, Michele Furlato, et al.
Pageof 7